Orange You Glad You Didn’t Try This: FTC and FDA Crack Down on Improperly Listed Patents

Event Details

On September 14, 2023, the Federal Trade Commission (“FTC”) issued a Statement Concerning Brand Drug Manufacturers’ Improper Listing of Patents in the Orange Book. Since that time the FTC has challenged over 500 patents listed in the Orange Book. Please join AGG Intellectual Property attorneys Matt Zapadka and Rich Cleland for a complimentary webinar exploring the legal justification for the FTC’s position that improperly listed patents may violate Section 5 of the FTC Act. This webinar will enhance your understanding of the risks and how to avoid them.

There will be an opportunity for Q&A at the end of this webinar.

Credits: 1 hour of CLE credit is approved by the State Bar of Georgia

To enhance your webinar experience with us, please make sure to access the webinar from outside of a VPN and close out of all other streaming services. The webinar is best viewed on a desktop or laptop computer. The recommended browser is Google Chrome.

Please click here to perform an automatic system check to confirm your system is compatible with the webinar.

Please click here to view the GoToWebinar attendee guide.